Altamira Therapeutics CYTOF
OTC CYTOF
$0.07 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Altamira Therapeutics (CYTOF) Capital Expenditures (2014 - 2017)

Updated

Altamira Therapeutics' Capital Expenditures was $103,087 in FY2024.

Analysis

Altamira Therapeutics (CYTOF) Capital Expenditures (2014 - 2017) Analysis & Trends

From FY2015 onward, Altamira Therapeutics has reported Capital Expenditures for 5 years.

  • Capital Expenditures shows a five-year compound annual growth rate of 9.9% (FY2019 to FY2024).
  • The FY2024 figure marks the highest annual Capital Expenditures since FY2016.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -74,003.07
Dec 31, 2016 255,804.25
Dec 31, 2015 161,520.40
Sep 30, 2015 -27,678.39
Dec 31, 2014 -11,154.16
Sep 30, 2014 -14,853.38
Jun 30, 2014 -10,519.19
Mar 31, 2014 -89,427.81
API Access

Altamira Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CYTOF&period=max&api_key=YOUR_API_KEY